Th2 cytokines can down-regulate the expression of airway epithelial angiotensin-converting enzyme 2 (ACE2) (21, 41, 42), which is the primary receptor of SARS-CoV-2, thereby reducing the prevalence and severity of COVID-19 patients. The gene discussed is ACE2; the disease is COVID-19.